Zhejiang Haiyan Power System Resources Environmental Technology (688565.SH) signed a 34.88 million yuan supply contract.
Power Source Technology (688565.SH) announced that the company recently signed a purchase contract with Gansu Guoneng Badan Jilin First Power Generation Co., Ltd. for condensate water purification equipment, with a total contract amount of 34.88 million yuan (including tax).
Zhejiang Haiyan Power System Resources Environmental Technology (688565.SH) announced that the company recently signed a purchase contract for condensate water treatment equipment with Gansu Guoneng Badan Jilin First Power Generation Co., Ltd. The contract amount is 34.88 million yuan (including tax).
The signing of the purchase contract for condensate water treatment equipment for the 41000MW coal-fired power project at the Gansu Badan Jilin Desert New Energy Base by the National Energy Group will further consolidate the company's leading position in the thermal power market. It will also help enhance the company's profitability and core competitiveness, and will have a positive impact on the company's business development and operating performance.
Related Articles
YNBY INTL (00030) spent 4.125 million Hong Kong dollars on July 9 to repurchase 15 million shares.
DONGYUE GROUP (00189) announces positive profit growth, with an expected increase of over 31% in net profit attributable to shareholders in the first half of the year compared to the same period last year.
The joint development of the Phase III clinical trial of the heart drug did not reach the primary endpoint, causing the stock prices of Astrazeneca PLC Sponsored ADR (AZN.US) and Ionis (IONS.US) to plummet.
YNBY INTL (00030) spent 4.125 million Hong Kong dollars on July 9 to repurchase 15 million shares.
DONGYUE GROUP (00189) announces positive profit growth, with an expected increase of over 31% in net profit attributable to shareholders in the first half of the year compared to the same period last year.
The joint development of the Phase III clinical trial of the heart drug did not reach the primary endpoint, causing the stock prices of Astrazeneca PLC Sponsored ADR (AZN.US) and Ionis (IONS.US) to plummet.
RECOMMEND
